Gene · 59341
Papers4,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic and allelic heterogeneity in 248 Indians with skeletal dysplasia. | Eur J Hum Genet | 2025 | 39706863 | PubTator, text mining | PubMed |
| Transient receptor potential vanilloid 4 gene-deficiency attenuates the inhibitory effect of 5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid on vascular permeability in mice. | J Pharmacol Sci | 2025 | 39706643 | PubTator, text mining | PubMed |
| Endothelial Cell TRPV4 Channels Turn to the Dark Side During Hypertension. | Hypertension | 2025 | 39693416 | PubTator, text mining | PubMed |
| The role of TRP channels in lung fibrosis: Mechanisms and therapeutic potential. | Int J Biochem Cell Biol | 2025 | 39672503 | PubTator, text mining | PubMed |
| In vitro examination of Piezo1-TRPV4 dynamics: implications for placental endothelial function in normal and preeclamptic pregnancies. | Am J Physiol Cell Physiol | 2025 | 39652778 | PubTator, text mining | PubMed |
| Conserved and Unique Mitochondrial Target Sequence of TRPV4 Can Independently Regulate Mitochondrial Functions. | Proteins | 2025 | 39648544 | PubTator, text mining | PubMed |
| TRPV4 stimulates colonic afferents through mucosal release of ATP and glutamate. | Br J Pharmacol | 2025 | 39626870 | PubTator, text mining | PubMed |
| New magnetic iron nanoparticle doped with selenium nanoparticles and the mechanisms of their cytoprotective effect on cortical cells under ischemia-like conditions. | Arch Biochem Biophys | 2025 | 39613283 | PubTator, text mining | PubMed |
| TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway. | Cell Oncol (Dordr) | 2025 | 39612152 | PubTator, text mining | PubMed |
| S1P/S1PRs-TRPV4 axis is a novel therapeutic target for persistent pain and itch in chronic dermatitis. | Br J Pharmacol | 2025 | 39581852 | PubTator, text mining | PubMed |
| Transient Receptor Potential Channels in Vascular Mechanotransduction. | Am J Hypertens | 2025 | 39579078 | PubTator, text mining | PubMed |
| Deficiency of endothelial TRPV4 cation channels ameliorates experimental abdominal aortic aneurysm. | Eur J Pharmacol | 2025 | 39577553 | PubTator, text mining | PubMed |
| Qisheng wan decoction alleviates the inflammation of CCI rats via TRP channels. | J Ethnopharmacol | 2025 | 39490711 | PubTator, text mining | PubMed |
| Osteopontin Regulates AQP4 Expression by TRPV4 Activation in Müller Cells: Implications for Retinal Homeostasis. | Mol Neurobiol | 2025 | 39485629 | PubTator, text mining | PubMed |
| Increased TRPV4 Channel Expression Enhances and Impairs Blood Vessel Function in Hypertension. | Hypertension | 2025 | 39440451 | PubTator, text mining | PubMed |
| Is It Possible to Regenerate the Underactive Detrusor? Part 1. Molecular and Stem Cell Therapies Targeting the Urinary Bladder and Neural Axis - ICI-RS 2024. | Neurourol Urodyn | 2025 | 39370871 | PubTator, text mining | PubMed |
| TRPV4 Channel in Neurological Disease: from Molecular Mechanisms to Therapeutic Potential. | Mol Neurobiol | 2025 | 39333347 | PubTator, text mining | PubMed |
| TRPV4 Blockage Inhibits the Neurogenesis in the Adult Hippocampal Dentate Gyrus Following Pilocarpine‑Induced Status Epilepticus. | Mol Neurobiol | 2025 | 39312069 | PubTator, text mining | PubMed |
| Spheroid-Hydrogel-Integrated Biomimetic System: A New Frontier in Advanced Three-Dimensional Cell Culture Technology. | Cells Tissues Organs | 2025 | 39265553 | PubTator, text mining | PubMed |
| Lasmiditan ameliorates serotonergic itch in mice: Possible involvement of 5-HT1F receptors. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39115558 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/59341/papers?page=18